To cite this paper use one of the standards below:
In the ongoing battle against diabetes, innovative solutions are emerging at the intersection of biology and technology. Here, I will explore the exciting world of biology-mimicking systems designed to combat diabetes. We delve into the realm of biomimetic systems, nanoparticles, advanced cell culture methods, and plant-derived compounds that hold promise in the fight against diabetes. Biomimetic systems, such as artificial pancreas designs, will be shown for their potential to mimic the natural glucose regulation mechanisms of the human body. The research to improve these devices design and components is ongoing and also aims to expand their use in varying clinicopathological cohorts, including by age-groups. Furthermore, how nanotechnology is being harnessed for precise drug delivery (e.g. insulin, GLP-1 receptor agonists, DPP-4, meglitinides) in the management of diabetes, will be discussed, optimizing therapeutic outcomes while minimizing side effects. Parallelly to the technology, cutting-edge cell culture methodologies are shedding light in elucidating the mechanisms underlying diabetes pathogenesis and treatment responses. Plant-based drug candidates will also be mentioned, emphasizing their potential to modulate metabolic pathways and mitigate diabetes-related complications thus encompassing possible novel therapeutic avenues. This quick exploration of biology-mimicking systems and their integration with advanced scientific methodologies underscores the promise of these innovations in enhancing our understanding of diabetes, improving diagnostics, and advancing personalized therapeutic strategies. These groundbreaking approaches offer novel and great performance for understanding diabetes and can be allies in the quest for a diabetes-free future
With nearly 200,000 papers published, Galoá empowers scholars to share and discover cutting-edge research through our streamlined and accessible academic publishing platform.
Learn more about our products:
This proceedings is identified by a DOI , for use in citations or bibliographic references. Attention: this is not a DOI for the paper and as such cannot be used in Lattes to identify a particular work.
Check the link "How to cite" in the paper's page, to see how to properly cite the paper